Showing 1 - 4 results of 4 for search 'Chenhong Xu' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Chenhong Xu
Showing 1 - 4 results of 4 for search 'Chenhong Xu', query time: 0.03s Refine Results
  1. 1
    Sestrin2 Suppresses Classically Activated Macrophages-Mediated Inflammatory Response in Myocardial Infarction through Inhibition of mTORC1 Signaling

    Sestrin2 Suppresses Classically Activated Macrophages-Mediated Inflammatory Response in Myocardial Infarction through Inhibition of mTORC1 Signaling by Keping Yang, Chenhong Xu, Yunfeng Zhang, Shaolin He, Dazhu Li

    Published 2017-06-01
    Get full text
    Article
  2. 2
    Temperature-dependent dielectric and energy-storage properties of Pb(Zr,Sn,Ti)O3 antiferroelectric bulk ceramics

    Temperature-dependent dielectric and energy-storage properties of Pb(Zr,Sn,Ti)O3 antiferroelectric bulk ceramics by Xuefeng Chen, Zhen Liu, Chenhong Xu, Fei Cao, Genshui Wang, Xianlin Dong

    Published 2016-05-01
    Get full text
    Article
  3. 3
    Giant enhancement and quick stabilization of capacitance in antiferroelectrics by phase transition engineering

    Giant enhancement and quick stabilization of capacitance in antiferroelectrics by phase transition engineering by Tengfei Hu, Zhengqian Fu, Xiaowei Liu, Linhai Li, Chenhong Xu, YongXin Zhou, Fei Cao, Jiake Xia, Xuefeng Chen, Genshui Wang, Fangfang Xu

    Published 2024-10-01
    Get full text
    Article
  4. 4
    Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China

    Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China by Zhen Wang, Xin Zhang, Yanling Qu, Shuyang Zhang, Yundai Chen, Xiaoping Chen, Xin Qi, Peijing Liu, Shuqin Liu, Shan Jiang, Ronghai Man, Liping He, Ling Wu, Zhanquan Li, Yijun Shang, Zhaohui Qiu, Feng Liu, Chenhong Xu, Chunlin Lai, Junbo Ge

    Published 2023-06-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs